Jorge Nadal

612 total citations
24 papers, 407 citations indexed

About

Jorge Nadal is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Jorge Nadal has authored 24 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Jorge Nadal's work include Advanced Breast Cancer Therapies (5 papers), Breast Cancer Treatment Studies (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). Jorge Nadal is often cited by papers focused on Advanced Breast Cancer Therapies (5 papers), Breast Cancer Treatment Studies (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). Jorge Nadal collaborates with scholars based in Argentina, Netherlands and United States. Jorge Nadal's co-authors include Godefridus J. Peters, Herbert M. Pinedo, E. Laurensse, H. M. Pinedo, C.J. van Groeningen, Stanley G. Payne, Gilberto Schwartsmann, W J van der Vijgh, J. Lankelma and C.J. van Groeningen and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Clinical Cancer Research.

In The Last Decade

Jorge Nadal

23 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jorge Nadal Argentina 11 197 164 84 68 36 24 407
Radhika Gogoi United States 13 176 0.9× 185 1.1× 81 1.0× 52 0.8× 24 0.7× 51 554
Teresa J. Melink United States 10 119 0.6× 146 0.9× 108 1.3× 38 0.6× 13 0.4× 24 388
T. Facchini France 9 303 1.5× 77 0.5× 129 1.5× 90 1.3× 12 0.3× 22 401
Αngeliki Andrikopoulou Greece 13 220 1.1× 158 1.0× 78 0.9× 89 1.3× 37 1.0× 41 438
Andrew Peniket United Kingdom 12 177 0.9× 329 2.0× 45 0.5× 22 0.3× 23 0.6× 22 772
Gary Altwerger United States 14 189 1.0× 139 0.8× 46 0.5× 82 1.2× 7 0.2× 40 519
Míriam Méndez Spain 12 168 0.9× 245 1.5× 154 1.8× 120 1.8× 19 0.5× 54 528
Anca Chelariu-Raicu Germany 12 142 0.7× 179 1.1× 87 1.0× 53 0.8× 15 0.4× 42 434
Kyung‐Hun Lee South Korea 11 205 1.0× 143 0.9× 58 0.7× 73 1.1× 10 0.3× 20 360
Limei Yin China 11 243 1.2× 143 0.9× 64 0.8× 67 1.0× 10 0.3× 19 508

Countries citing papers authored by Jorge Nadal

Since Specialization
Citations

This map shows the geographic impact of Jorge Nadal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Nadal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Nadal more than expected).

Fields of papers citing papers by Jorge Nadal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge Nadal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Nadal. The network helps show where Jorge Nadal may publish in the future.

Co-authorship network of co-authors of Jorge Nadal

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge Nadal. A scholar is included among the top collaborators of Jorge Nadal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge Nadal. Jorge Nadal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gill, Melissa, Gonzalo Gomez-Abuin, Cristina Nanni, et al.. (2024). 283P Immune-mediated secondary adrenal insufficiency is more commonly found in younger patients undergoing neoadjuvant treatment for early breast cancer. Annals of Oncology. 35. S333–S333. 1 indexed citations
3.
4.
Nadal, Jorge, et al.. (2024). The Emerging Role of Tertiary Lymphoid Structures in Breast Cancer: A Narrative Review. Cancers. 16(2). 396–396. 9 indexed citations
5.
6.
7.
Enrico, Diego, Luisina Bruno, Mora Amat, et al.. (2022). CDK4/6 inhibitors outcomes in patients with advanced breast cancer based on HER2-low expression.. Journal of Clinical Oncology. 40(16_suppl). 1056–1056. 9 indexed citations
8.
9.
Nadal, Jorge, et al.. (2019). Cardiotoxicity Alerts during Treatment with Trastuzumab in Breast Cancer at Four-year Follow-up. 87(2). 103–108. 1 indexed citations
10.
Rizzo, Manglio, María Paula Roberti, M. Betina Pampena, et al.. (2018). High neutrophil to lymphocyte ratio and decreased CD69<sup>+</sup>NK cells represent a phenotype of high risk in early-stage breast cancer patients. OncoTargets and Therapy. Volume 11. 2901–2910. 11 indexed citations
11.
Nervo, Adrián, et al.. (2018). Predictive Factors for Non-Sentinel Lymph Node Metastasis in Patients with ACOSOG Z0011 Criteria. Breast Care. 13(6). 434–438. 7 indexed citations
12.
13.
Rosenberg, Moisés, et al.. (2011). Sternal Metastasis of Breast Cancer: Ex Vivo Hypothermia and Reimplantation. The Annals of Thoracic Surgery. 91(2). 584–586. 4 indexed citations
14.
Peters, Godefridus J., et al.. (1991). Clinical and Pharmacologic Study of Orally Administrated Uridine. JNCI Journal of the National Cancer Institute. 83(6). 437–442. 55 indexed citations
15.
Peters, Godefridus J., Gilberto Schwartsmann, Jorge Nadal, et al.. (1990). In vivo inhibition of the pyrimidine de novo enzyme dihydroorotic acid dehydrogenase by brequinar sodium (DUP-785; NSC 368390) in mice and patients.. PubMed. 50(15). 4644–9. 74 indexed citations
16.
Peters, Godefridus J., Jorge Nadal, E. Laurensse, Eric de Kant, & Herbert M. Pinedo. (1990). Retention of in vivo antipyrimidine effects of brequinar sodium (DUP-785; NSC 368390) in murine liver, bone marrow and colon cancer. Biochemical Pharmacology. 39(1). 135–144. 25 indexed citations
17.
Nadal, Jorge, Cees J. van Groeningen, Herbert M. Pinedo, & Godefridus J. Peters. (1989). Schedule-dependency of in vivo modulation of 5-fluorouracil by leucovorin and uridine in murine colon carcinoma. Investigational New Drugs. 7(2-3). 163–172. 31 indexed citations
18.
Peters, Godefridus J., et al.. (1989). The Relationship between Dihydroorotic Acid Dehydrogenase and In Vitro and In Vivo Cytostatic Effects of Brequinar Sodium (DUP-785; NSC 368390). Advances in experimental medicine and biology. 253B. 375–382. 7 indexed citations
19.
Payne, Stanley G. & Jorge Nadal. (1968). La Poblacion Espanola (siglos XVI-XX). The American Historical Review. 73(5). 1546–1546. 23 indexed citations
20.
Nadal, Jorge & F Ponz. (1966). Inhibition of the active transport of sugars by x-irradiation "in vitro" of intestinal sacs.. PubMed. 22(3). 105–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Radhika Gogoi Breakdown of academic impact, for papers by Teresa J. Melink Breakdown of academic impact, for papers by T. Facchini Breakdown of academic impact, for papers by Αngeliki Andrikopoulou Breakdown of academic impact, for papers by Andrew Peniket Breakdown of academic impact, for papers by Gary Altwerger Breakdown of academic impact, for papers by Míriam Méndez Breakdown of academic impact, for papers by Anca Chelariu-Raicu Breakdown of academic impact, for papers by Kyung‐Hun Lee Breakdown of academic impact, for papers by Limei Yin
Rankless by CCL
2026